eISSN: 2345-4202  
J Nephropharmacol. 2018;7(2):68-73.

Case Report

The demise of contrast nephropathy; can this be true? A contrarian view; a representative case report of contrast nephropathy from Mayo Clinic Health System in Northwestern Wisconsin

Macaulay Amechi Onuigbo 1,2 * , Eileen Samuel 2, Nneoma Agbasi 3

1 Mayo Clinic College of Medicine, Rochester, MN, USA
2 Department of Nephrology, Mayo Clinic Health System, Eau Claire, WI, USA
3 North East London NHS Foundation Trust, United Kingdom
*Corresponding author: Macaulay Amechi Onuigbo, Email: Email: onuigbo.macaulay@mayo.edu

Abstract

In the cognate nephrology literature, a few recent publications from major academic centers in the United States have suggested that the incidence of contrast nephropathy was exaggerated and overstated. These investigators have concluded that intravenous contrast material administration was not associated with an increased risk of acute kidney injury (AKI), emergent dialysis, and short-term mortality in a cohort of patients with diminished renal function. As a contrarian opinion, we first describe a clear cut case of contrast-nephropathy resulting in AKI requiring hemodialysis treatment managed in the Renal Unit of the Mayo Clinic Health System, Northwestern Wisconsin, in the Spring of 2017. We subsequently revisit the overwhelming evidence-base in the English literature that supports the enormous impact of contrast-nephropathy as a clinical syndrome. We finally posit that these recent repudiations of the existence and significance of contrast-nephropathy as a significant clinical entity represent an overreach in statistical expertise. There is no basis for a requiem song over contrast-nephropathy

Implication for health policy/practice/research/medical education:

Recently in the cognate nephrology literature, there has been a spate of publications suggesting that contrast nephropathy is an exaggerated and overstated reality. Indeed, some investigators have lately concluded that intravenous contrast material administration was not associated with an increased risk of acute kidney injury (AKI), emergent dialysis, and short-term mortality in a cohort of patients with diminished renal function. We describe a clear cut case of contrast-nephropathy resulting in AKI requiring hemodialysis treatment managed in the Renal Unit of the Mayo Clinic Health System, Northwestern Wisconsin, in the Spring of 2017, and subsequently revisit the overwhelming evidence in support of the enormous impact of contrastnephropathy as a clinical syndrome in the nephrology literature. We submit that these recent repudiations of the existence of contrast-nephropathy as a significant clinical entity represent an overreach. There is no basis for a requiem song over contrastnephropathy.

Please cite this paper as: Onuigbo MA, Samuel E, Agbasi N. The demise of contrast nephropathy; can this be true? A contrarian view; a representative case report of contrast nephropathy from Mayo Clinic Health System in Northwestern Wisconsin. J Nephropharmacol. 2018;7(2):68-73. 

First name
 
Last name
 
Email address
 
Comments
 
Security code


Submitted: 22 Aug 2017

Accepted: 04 Dec 2017
First published online: 31 Dec 2017
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract Page Views: 95
PDF Downloads: 176
Full Text Views: 0